Li Q, Guan XH, Wu P, Wang XY, Zhou L, Tong YQ, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–54.

Article  CAS  PubMed  Google Scholar 

Lu HZ, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization. WHO coronavirus (COVID-19) dashboard. 2023. https://data.who.int/dashboards/covid19.

Li QQ, Nie JH, Wu JJ, Zhang L, Ding RX, Wang HX, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184(9):2362–71.

Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022;376(6593):596–603.

Article  Google Scholar 

Cui Z, Liu P, Wang N, Wang L, Fan KY, Zhu QH, et al. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. 2022;185(5):860–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tallei TE, Alhumaid S, AlMusa Z, Fatimawali, Kusumawaty D, Alynbiawi A, et al. Update on the omicron sub-variants BA.4 and BA.5. Rev Med Virol. 2023;33(1):e2391.

Xie Y, Choi T, Al-Aly Z. Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in fall-winter 2022–2023. JAMA. 2023;329(19):1697–9.

Article  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control and Prevention. COVID data tracker. 2024. https://covid.cdc.gov/covid-data-tracker.

Sarker R, Roknuzzaman ASM, Hossain MJ, Bhuiyan MA, Islam MR. The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life. Int J Surg. 2023;109(9):2851–2.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Cheng L, Lian R, Song Z, Tian J. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer. Biosci Trends. 2021;15(2):64–73.

Article  CAS  PubMed  Google Scholar 

Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ Br Med J. 2021;375:e068302.

Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 2021;54(8):1636–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hotez PJ. COVID-19 vaccines: the imperfect instruments of vaccine diplomacy. J Travel Med. 2022;29(8):taac063.

Li MC, Wang H, Tian LL, Pang ZH, Yang QK, Huang TQ, et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Tar. 2022;7(1):146–77.

Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, et al. mRNA vaccines for COVID-19 and diverse diseases. J Control Release. 2022;345:314–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmaz IC, Ipekoglu EM, Bulbul A, Turay N, Yildirim M, Evcili I, et al. Development and preclinical evaluation of virus-like particle vaccine against COVID-19 infection. Allergy. 2022;77(1):258–70.

Article  CAS  PubMed  Google Scholar 

R&D Blue Print. COVID-19 vaccine tracker and landscape. 2023. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed 30 Mar 2023.

Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng WZ, Rosenfeld AM, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science. 2021;374(6572):1214–30.

Article  Google Scholar 

Barouch DH. Covid-19 vaccines—immunity, variants, boosters. N Engl J Med. 2022;387(11):1011–20.

Article  CAS  PubMed  Google Scholar 

Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol. 2022;22(1):57–65.

Article  CAS  PubMed  Google Scholar 

Finazzi S, Perego M, Tricella G, Poole D, Ranieri VM, Evaluat GIG. SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure. Intensive Care Med. 2023;49(2):248–50.

Article  PubMed  PubMed Central  Google Scholar 

Caforio ALP. Receipt of mRNA vaccine against Covid-19 and myocarditis. N Engl J Med. 2021;385(23):2189–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu K, Wang Z, Qin M, Gao Y, Luo N, Xie W, et al. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Front Immunol. 2023;14:1113156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mittal A, Khattri A, Verma V. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathog. 2022;18(2): e1010260.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20.

Article  CAS  PubMed  Google Scholar 

Xu JB, Zhao SZ, Teng TS, Abdalla AE, Zhu W, Xie LX, et al. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses Basel. 2020;12(2):244–60.

Kesheh MM, Hosseini P, Soltani S, Zandi M. An overview on the seven pathogenic human coronaviruses. Rev Med Virol. 2022;32(2):e2282.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, et al. The establishment of reference sequence for SARS-CoV-2 and variation analysis. J Med Virol. 2020;92(6):667–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohaim MA, El Naggar RF, Clayton E, Munir M. Structural and functional insights into non-structural proteins of coronaviruses. Microb Pathog. 2021;150: 104641.

Article  CAS  PubMed  Google Scholar 

Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369(6501):330–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baggen J, Jacquemyn M, Persoons L, Vanstreels E, Pye VE, Wrobel AG, et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell. 2023;186(16):3427-42 e22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20.

Article  CAS  PubMed  Google Scholar 

Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16(1):69–90.

Article  PubMed  PubMed Central  Google Scholar 

Kakavandi S, Zare I, VaezJalali M, Dadashi M, Azarian M, Akbari A, et al. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Commun Signal. 2023;21(1):110–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization. WHO Coronavirus (COVID-19) dashboard. Variants [Dashboard]. 2023. https://data.who.int/dashboards/covid19/variants.

Aleem A, Akbar Samad AB, Vaqar S. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). StatPearls. Treasure Island, StatPearls Publishing. 2024.

Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Consortium C-GU, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162–77.

Liu Y, Liu J, Johnson BA, Xia H, Ku Z, Schindewolf C, et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Cell Rep. 2022;39(7):110829.

Article  CAS  PubMed